Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in Watford, the United Kingdom.

Earnings data Q4 2019

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

LONDON , March 22, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will it showcase its latest innovations for Orthopaedic Reconstruction and Robotics during the American Academy of Orthopaedic Surgeons 2022 Annual Meeting being held in Chicago, IL. Introducing the Smith+Nephew Cementless Knee Continuum of Care Cementless knee implants are serving a resurgent segment1 driven by the potential for better long-term fixation through biologic integration2,3, shorter operating times4, and the shift to Ambulatory Surgery Centers (ASCs).5 Smith+Nephew is now the only company in the US with a cementless commercial offering for total knees with the recent launch of the LEGION™ CONCELOC™ Cementless Total Knee System - and partial knees with the acquisition of Engage Surgical and the ENGAGE ™ Cementless Partial Knee System earlier this year.

Smith+Nephew to showcase latest Orthopaedic advancements in Cementless Knees, Total Hip Arthroplasty and Robotics at AAOS 2022 Annual Meeting

LONDON , March 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest Sports Medicine innovations for joint repair and arthroscopic enabling technologies during the American Academy of Orthopaedic Surgeons 2022 Annual Meeting being held in Chicago, IL. The latest technologies include: FAST-FIX™ FLEX Meniscal Repair System: A surgeon-guided, bendable needle and shaft providing access to all zones of the meniscus.1-3 Improving access leads to a greater opportunity to repair the meniscus rather than remove it, which can result in long-term benefits to the patient.4-6 INTELLIO™ Connected Tower: Brings together Smith+Nephew's leading capital technologies across its INTELLIO IMAGING, INTELLIO RESECTION and INTELLIO FLUID & ACCESS portfolios to deliver the "Power of Unity" to customers.

Smith+Nephew to feature Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2022 Annual Meeting

LONDON, March 15, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces it has kicked-off the OXINIUM Technology Tour of Change mobile exhibit. OXINIUM (Oxidized Zirconium) Technology has established itself as the best performing bearing with the lowest risk of revision in total hip arthroplasty (THA) at 9-17 years1-4, with strong clinical performance in knees.5,6 The Tour of Change is a 550 square foot mobile exhibit that will visit leading Orthopaedic centers in approximately 20 U.S. cities over 12 weeks.

Smith+Nephew embarks on the OXINIUM™ Technology Tour of Change; a mobile learning exhibit to showcase the best performing bearing for total hip arthroplasty

Surging commodity prices lifted London stocks to positive territory on Tuesday, as geopolitical tensions swirled around investors.

London Markets: Hargreaves Lansdown shares slump, while Smith & Nephew soar as U.K. stocks grapple with geopolitics

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q4 2021 Results - Earnings Call Transcript

Smith & Nephew PLC (LSE:SN) said pre-tax profit more than doubled in 2021, helped by strong sales in its sports medicine & ENT and wound care segments, all of which delivered revenue higher than in pre-Coronavirus (COVID-19) 2019. The medical group also revealed Dr Deepak Nath was appointed as the new chief executive officer (CEO), succeeding Roland Diggelmann, who will step down by mutual agreement.

Smith & Nephew FY operating profits double; CEO to depart

LONDON, Feb. 10, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the first completed surgery using its JOURNEY II Medial Dished (MD) System for total knee arthroplasty (TKA). The procedure was performed by Dr. Ran Schwarzkopf, Orthopedic Adult Hip and Knee Reconstruction at NYU Langone Health.

Smith+Nephew announces first surgery for its JOURNEY™ II Medial Dished System for total knee arthroplasty

Smith+Nephew's (SNN) acquisition of Engage Surgical reinforces its growth strategy while expanding its Orthopaedic Reconstruction product line.

Smith+Nephew (SNN) to Acquire Orlando-Based Engage Surgical

Medical devices manufacturer continues to suffer from lower demand than pre-pandemic, but recovery is in progress. The company has set out a growth plan but I don't find it persuasive.

Smith & Nephew: Valuation Looking More Attractive

LONDON, Jan. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the expansion of indications on its CORI Surgical System - the industry's most advanced and efficient1,* handheld robotic solution in total knee arthroplasty1,*,† - to now include total hip arthroplasty (THA). Smith+Nephew's RI.HIP NAVIGATION - designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment for THA – is now available for use on its CORI System.

Smith+Nephew expands next-generation handheld robotic-assisted CORI™ Surgical System into total hip arthroplasty with RI.HIP NAVIGATION

LONDON, Jan. 24, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce new indications for use for its PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems. The U.S. Food and Drug Administration (FDA) cleared the systems for use on  closed surgical incisions, to aid in reducing the incidence of: Superficial and deep incisional surgical site infections (SSIs) for high risk patients in Class I and Class II wounds Post-operative seroma Dehiscence The development of post-operative surgical site complications (SSCs), such as surgical wound dehiscence, are a substantial burden for patients and healthcare systems, globally1.

Smith+Nephew's PICO™ 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in reducing the incidence of both deep and superficial incisional surgical site infections and dehiscence

LONDON, Jan. 19, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the acquisition of Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the US. This acquisition strongly supports Smith+Nephew's strategy for growth by transforming its business through innovation and acquisition, while also providing differentiation for its customers.

Smith+Nephew acquires novel cementless partial knee system

Smith+Nephew (SNN) debuts new brand of enabling technology solutions as well as its next-generation handheld robotics platform in Canada.

Smith+Nephew (SNN) Introduces Real Intelligence & CORI System

Smith+Nephew's (SNN) CORI system enables each patient to have a knee replacement that is shape-matched and aligned to their specific anatomy.

Smith+Nephew (SNN) Rolls Out Robotic Assisted Surgical System

LONDON, Nov. 23, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the launch of CORI™ handheld robotics, an advanced system for both total and partial knee arthroplasties. The CORI system is a compact and fully mobile5 solution incorporating a 3-D intra-operative imaging system with an advanced robotic sculpting tool.

Smith+Nephew launches 'turn-key' robotic-assisted surgical system; designed to quickly augment the orthopaedic team's skills set for greater accuracy(1-3) ¥ improved outcomes(4), and potentially an immediate scalable solution to NHS

LONDON, Nov. 16, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovation centre, based in Munich, Germany. The new innovation centre will bring healthcare professionals from Europe, Middle East and Africa together with Smith+Nephew's R&D and medical education teams to explore digital surgery and robotics techniques and technologies.

Smith+Nephew announces digital surgery and robotics innovation centre in Europe

State-of-the-art centre to focus on digital and robotic surgery LONDON, Nov. 9, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its first dedicated Medical Education Centre to support customers across the Asia Pacific region. Strategically located in Singapore, the centre will support the safe and effective use of Smith+Nephew's products as well as the professional development of healthcare professionals across the region.

Smith+Nephew establishes its first Medical Education Centre for the Asia Pacific region in Singapore

Smith & Nephew is 165 years old, highly adaptable, and will likely outlive us all. And our grandchildren. SNN has paid dividends on its ordinary shares every year since 1937.

Smith & Nephew Is A Premium Brand That Should Deliver Something Special

Smith & Nephew PLC (LSE:SN) said it expects its full-year results to come in at the low end of guidance, after the impact of the COVID-19 Delta variant and supply chain disruptions hit revenue in its Orthopaedics business. The company said it is implementing a range of actions to address the supply chain challenges.

Smith & Nephew sees full-year performance at low end of guidance on impact from Delta variant and supply chain issues

LONDON, Nov. 2, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of its LEGION CONCELOC Cementless Total Knee System (TKS) and first completed surgical procedures.  CONCELOC Advanced Porous Titanium is a patented, proprietary, 3D printed porous structure technology first used in Smith+Nephew's leading REDAPT™  Revision Hip System, launched in 2016.

Smith+Nephew introduces the LEGION™ CONCELOC™ Cementless Total Knee System with proprietary 3D printed Advanced Porous Titanium technology

LONDON, Oct. 26, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a systematic review and meta-analysis of comparative trials to determine the efficacy of its IODOSORB 0.9% Cadexomer Iodine Range* on chronic wounds versus standard care specific to the wound type.1 The review found that wounds were more than twice as likely to completely heal with IODOSORB Range than with standard care, and significantly greater reductions in wound area** were observed after 8 weeks of treatment versus standard care. Use of IODOSORB Range helped reduce barriers to healing such as exudate, slough, pus, debris and bacteria, significantly reducing wound area** and increasing the chance of healing chronic wounds compared with standard care.1 Venous leg ulcers (VLUs), diabetic foot ulcers (DFUs) and pressure ulcers were included in the study.

Smith+Nephew's IODOSORB™ Range shown more than twice as likely to heal wounds than standard care

Smith & Nephew PLC shares represent a “rare value opportunity”, according to a leading investment bank that has reiterated its bullish stance on and price target for stock in the medical devices giant. Credit Suisse reckons November 4's trading update could act as a catalyst for the price, though it admits there may also be some pressures – including price and technology pressures and dilutive M&A.

Smith & Nephew shares represent a “rare value opportunity”, according to a leading investment bank

Smith+Nephew (SNN) introduced the RI.HIP NAVIGATION software on the CORI Surgical System and announced the commercial availability of RI.INSIGHTS at the AAOS 2021 Annual Meeting.

Smith+Nephew (SNN) Releases New Features for Hip Arthroplasty

LONDON , Sept. 1, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of two significant new technologies to its total knee arthroplasty (TKA) portfolio - the JOURNEY II Medial Dished (MD) for TKA and SYNC Performance Instruments.

Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio

LONDON , Sept. 1, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces significant enhancements to its Real Intelligence digital ecosystem and surgical robotics programs at the American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting in San Diego.

News for Smith & Nephew Stock (SNN)